1. Home
  2. KYMR vs ATS Comparison

KYMR vs ATS Comparison

Compare KYMR & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • ATS
  • Stock Information
  • Founded
  • KYMR 2015
  • ATS 1978
  • Country
  • KYMR United States
  • ATS Canada
  • Employees
  • KYMR N/A
  • ATS N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • ATS
  • Sector
  • KYMR Health Care
  • ATS
  • Exchange
  • KYMR Nasdaq
  • ATS Nasdaq
  • Market Cap
  • KYMR 2.2B
  • ATS 2.3B
  • IPO Year
  • KYMR 2020
  • ATS 2023
  • Fundamental
  • Price
  • KYMR $25.97
  • ATS $24.41
  • Analyst Decision
  • KYMR Buy
  • ATS Sell
  • Analyst Count
  • KYMR 13
  • ATS 2
  • Target Price
  • KYMR $56.69
  • ATS $30.50
  • AVG Volume (30 Days)
  • KYMR 847.3K
  • ATS 164.9K
  • Earning Date
  • KYMR 05-01-2025
  • ATS 01-01-0001
  • Dividend Yield
  • KYMR N/A
  • ATS N/A
  • EPS Growth
  • KYMR N/A
  • ATS N/A
  • EPS
  • KYMR N/A
  • ATS 0.63
  • Revenue
  • KYMR $47,072,000.00
  • ATS $1,908,353,570.00
  • Revenue This Year
  • KYMR $16.24
  • ATS N/A
  • Revenue Next Year
  • KYMR $22.41
  • ATS $13.22
  • P/E Ratio
  • KYMR N/A
  • ATS $38.59
  • Revenue Growth
  • KYMR N/A
  • ATS N/A
  • 52 Week Low
  • KYMR $19.45
  • ATS $20.90
  • 52 Week High
  • KYMR $53.27
  • ATS $35.42
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 44.70
  • ATS 45.59
  • Support Level
  • KYMR $24.43
  • ATS $23.94
  • Resistance Level
  • KYMR $26.06
  • ATS $25.35
  • Average True Range (ATR)
  • KYMR 2.36
  • ATS 1.33
  • MACD
  • KYMR 0.41
  • ATS 0.10
  • Stochastic Oscillator
  • KYMR 70.12
  • ATS 64.76

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

Share on Social Networks: